Since the beginning of the pandemic the Oxford-AstraZeneca vaccine has been plagued by confusion and controversy. The vaccine has been authorised in over 100 countries, tens of millions of doses have been administered, and it has been demonstrated to be safe and effective. However, over the past few weeks the vaccine has again been in the headlines.In this episode of Coronapod, we discuss all of these controversies and ask how they may the reputation of the vaccine, and what that could mean for roll-outs moving forward.News: Latest results put Oxford–AstraZeneca COVID vaccine back on trackNews: What scientists do and don’t know about the Oxford–AstraZeneca COVID vaccineSubscribe to Nature Briefing, an unmissable daily round-up of science news, opinion and analysis free in your inbox every weekday.Never miss an episode: Subscribe to the Nature Podcast on Apple Podcasts, Google Podcasts, Spotify or your favourite podcast app. Head here for the Nature Podcast RSS feed. Hosted on Acast. See acast.com/privacy for more information.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.